Bhyrappa defends Modi over Rafale scam, claims Rahul was born in Italy!

coastaldigest.com news network
October 1, 2018

Mysuru, Oct 1: Veteran Kannada novelist S L Bhyrappa, who is known for his pro-Sangh Parivar stance, has strongly defended Prime Minister Narendra Modi over multi-billion Rafale scam.

Addressing a symposium on novel ‘Uttara Kanda’, here, Bhyrappa slammed the All India Congress Committee (AICC) president Rahul Gandhi for accusing Modi of joining hands with Anil Ambani of Reliance Group and looting crores of rupees in Rafale deal.

“In our country, it is easy to make a person step down from his position but, it is difficult to prove the allegations. Is there any punishment for those who make false allegations,” he questioned.

“Is it right to give power to Rahul Gandhi, who was born in Italy,” Bhyrappa asked. (In fact, Rahul Gandhi was born in New Delhi, the capital of India, and not in Italy)

Bhyrappa then came down heavily on chief minister H D Kumaraswamy led coalition government of Karnataka, and said the person, who is in power, must understand the financial health of the state before introducing any scheme. “It is not right to introduce the schemes to please a section of the society,” he said.

Comments

AU
 - 
Monday, 1 Oct 2018

Useless fellow with baseless talk

Suresh
 - 
Monday, 1 Oct 2018

Modi joined hands with ambani (who has no experiance or expertise in that particular field) for make their family great, not for indian people

Mohan
 - 
Monday, 1 Oct 2018

He has no business. He may be expecting some award from Modi govt. so that he is praising looter

Rahul
 - 
Monday, 1 Oct 2018

He is pretending he has much knowledgw by addressing as novelist. Before criticising a person in a public sphere, should learn some background data about him.

Danish
 - 
Monday, 1 Oct 2018

He spoiled dignity of novelists

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 22,2020

Mangaluru, May 22: Dakshina Kannada today reported a fresh case of coronavirus infection, taking the coastal district's tally to 62. 

The new patient is a 29-year-old womon, who was under instituional quarantine monitored by the district administration in Belthangady. 

She had returned from Mumbai on May 18. Her throat swabs were sent for covid-19 testing on the following day and today she received positive result.

Out of the 62 covid-19 cases detected in Dakshina Kannada so far, only 50 are residents of the district. Among 12 others 4 are from Kasaragod and 3 from Karkala, 2 each from Uttara Kannada and Mumbai, and 1 from Kalaburgi.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 16,2020

Haveri, Jan 16: Karnataka Chief Minister B S Yediyurappa on Wednesday hinted at inducting 16 MLAs into the Cabinet which was due for expansion despite the fact that it was a difficult task.

Participating in a function of Choudayya Community here, he further said one should understand the difficulty faced to undertake cabinet expansion in the prevailing situation and whoever gives suggestion should understand the circumstances otherwise the statements would lead to confusion among the community and people of the state.

He stated that 'as many as 17 MLAs resigned to make me Chief Minister and now their community people want their leader to become Minister, it is very difficult to satisfy all of them'.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.